Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|
| Total income (before exceptional items) | 212† | 154† | 147† | 144† |
| Net profit | 13 | 10 | 8 | 7 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| HARESH KAPURLAL MEHTA | Executive Director | June 30, 2026 |
| HARSHIT HARESH MEHTA | Executive Director | June 30, 2026 |
| MAHESHKUMAR DARJI | Executive Director | June 30, 2026 |
| RISHIT HARESHBHAI MEHTA | Executive Director | June 30, 2026 |
| ANUJ KISHORE MODY | Independent Director | June 30, 2026 |
| BHARAT NATHALAL RATHOD | Independent Director | June 30, 2026 |
| DEEPAK MAGANLAL VEKARIA | Independent Director | June 30, 2026 |
| DEEPESH RAJESH SHAH | Independent Director | June 30, 2026 |
| KUNAL TUSHAR VORA | Independent Director | June 30, 2026 |
| RITA HARESH MEHTA | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
